A new method can help researchers and clinicians gauge the likelihood that a gene is associated with a particular condition.

About 8 percent of non-inherited mutations in people with autism occur in only some of the body’s cells, according to a study of 20,000 people.

Autism researchers’ top priority should be shifting their focus to finding treatments for severe forms of the condition.

Families need more support from researchers in order for their heroic efforts to be optimally effective.

After a decade of fast-paced discovery, researchers are racing toward bigger datasets, more genes and a deeper understanding of the biology of autism.

How to best use a large volume of data to discover new genetic risk factors for autism is a matter of intense debate, particularly in light of historical challenges.

Autism researchers should ditch the false dichotomy between common inherited variants and much rarer random mutations.

The landscape of chemical modifications on the DNA of people with autism could reveal clues to the condition and lead to treatments.

Teasing out how genes interact can offer clues to autism’s causes and point to treatment targets.

A doctor decodes a rare genetic condition, burnout is a big problem in science, and an actor with autism will play the lead in “The Curious Incident of the Dog in the Night-Time.”